日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prefusion structure, evasion and neutralization of HSV-1 glycoprotein B

融合前结构、HSV-1糖蛋白B的逃避和中和

Ryan S Roark,Andrew J Schaub,Wei Shi,Maple Wang,Fabiana A Bahna,Jordan E Becker,Andrea Biju,Sue Chong,Haijuan Du,Yicheng Guo,Hsiang Hong,Phinikoula S Katsamba,Seetha M Mannepalli,Adam S Olia,Li Ou,Sarah K Rubin,Yosef Sabo,Mehin Suleiman,Malcolm L Wells,Baoshan Zhang,Cheng Cheng,Anum Glasgow,David D Ho,Yaoxing Huang,Theodore C Pierson,Reda Rawi,Tongqing Zhou,Lawrence Shapiro,Peter D Kwong

Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screening

从 DNA 编码化学库筛选中开发小分子非共价冠状病毒 3CL 蛋白酶抑制剂

Hengrui Liu, Arie Zask, Farhad Forouhar, Sho Iketani, Alana Williams, Daniel R Vaz, Dahlya Habashi, Karenna Choi, Samuel J Resnick, Seo Jung Hong, David H Lovett, Tian Bai, Alejandro Chavez, David D Ho, Brent R Stockwell3

A multiplex method for rapidly identifying viral protease inhibitors

一种快速鉴定病毒蛋白酶抑制剂的多重检测方法

Seo Jung Hong # ,Samuel J Resnick # ,Sho Iketani # ,Ji Won Cha ,Benjamin Alexander Albert ,Christopher T Fazekas ,Ching-Wen Chang ,Hengrui Liu ,Shlomi Dagan ,Michael R Abagyan ,Pavla Fajtová ,Bruce Culbertson ,Brooklyn Brace ,Eswar R Reddem ,Farhad Forouhar ,J Fraser Glickman ,James M Balkovec ,Brent R Stockwell ,Lawrence Shapiro ,Anthony J O'Donoghue ,Yosef Sabo ,Joel S Freundlich ,David D Ho ,Alejandro Chavez

XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1

XBB.1.5 单价 mRNA 疫苗加强针可诱导产生针对 XBB 亚型和 JN.1 的强效中和抗体。

Qian Wang ,Yicheng Guo ,Anthony Bowen ,Ian A Mellis ,Riccardo Valdez ,Carmen Gherasim ,Aubree Gordon ,Lihong Liu ,David D Ho

SARS-CoV-2 infection causes dopaminergic neuron senescence

SARS-CoV-2感染导致多巴胺能神经元衰老

Liuliu Yang ,Tae Wan Kim ,Yuling Han ,Manoj S Nair ,Oliver Harschnitz ,Jiajun Zhu ,Pengfei Wang ,So Yeon Koo ,Lauretta A Lacko ,Vasuretha Chandar ,Yaron Bram ,Tuo Zhang ,Wei Zhang ,Feng He ,Chendong Pan ,Junjie Wu ,Yaoxing Huang ,Todd Evans ,Paul van der Valk ,Maarten J Titulaer ,Jochem K H Spoor ,Robert L Furler O'Brien ,Marianna Bugiani ,Wilma D J Van de Berg ,Robert E Schwartz ,David D Ho ,Lorenz Studer ,Shuibing Chen

Human neutralizing antibodies target a conserved lateral patch on H7N9 hemagglutinin head

人类中和抗体靶向H7N9血凝素头部保守的侧向区域。

Manxue Jia # ,Hanjun Zhao # ,Nicholas C Morano # ,Hong Lu ,Yin-Ming Lui ,Haijuan Du ,Jordan E Becker ,Kwok-Yung Yuen ,David D Ho ,Peter D Kwong ,Lawrence Shapiro ,Kelvin Kai-Wang To ,Xueling Wu

Human neutralizing antibodies target a conserved lateral patch on H7N9 hemagglutinin head

人类中和抗体靶向H7N9血凝素头部保守的侧向区域。

Manxue Jia #,Hanjun Zhao #,Nicholas C Morano #,Hong Lu,Yin-Ming Lui,Haijuan Du,Jordan E Becker,Kwok-Yung Yuen ,David D Ho,Peter D Kwong,Lawrence Shapiro ,Kelvin Kai-Wang To ,Xueling Wu  0

Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine booster

XBB.1.5 mRNA 疫苗加强针接种后,强效 SARS-CoV-2 中和抗体可持续 6 个月

Qian Wang, Ian A Mellis, Yicheng Guo, Carmen Gherasim, Riccardo Valdez, Aubree Gordon, David D Ho, Lihong Liu

Developing inhibitory peptides against SARS-CoV-2 envelope protein

开发针对 SARS-CoV-2 包膜蛋白的抑制肽

Ramsey Bekdash, Kazushige Yoshida, Manoj S Nair, Lauren Qiu, Johnathan Ahdout, Hsiang-Yi Tsai, Kunihiro Uryu, Rajesh K Soni, Yaoxing Huang, David D Ho, Masayuki Yazawa

Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants

具有广泛特异性的 RBD 抗体对 SARS-CoV-2 JN.1 和其他变体具有强效中和作用

Michael S Piepenbrink #, Ahmed Magdy Khalil #, Ana Chang, Ahmed Mostafa, Madhubanti Basu, Sanghita Sarkar, Simran Panjwani, Yaelyn H Ha, Yao Ma, Chengjin Ye, Qian Wang, Todd J Green, James L Kizziah, Nathaniel B Erdmann, Paul A Goepfert, Lihong Liu, David D Ho, Luis Martinez-Sobrido, Mark R Walter,